The clinical management of neuroendocrine tumors with long-acting repeatable (LAR) octreotide: comparison with standard subcutaneous octreotide therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/11762334

Download in:

View as

General Info

PMID
11762334